Bionoid Pharma Inc
OTC:BINP
Bionoid Pharma Inc
Research & Development
Bionoid Pharma Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Bionoid Pharma Inc
OTC:BINP
|
Research & Development
-$600k
|
CAGR 3-Years
-66%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Research & Development
-$2.1B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-9%
|
|
|
Stryker Corp
NYSE:SYK
|
Research & Development
-$1.6B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-10%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Research & Development
-$2.8B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-8%
|
|
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
Research & Development
-$251.2m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-10%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Research & Development
-$1.3B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-21%
|
|
Bionoid Pharma Inc
Glance View
Bionoid Pharma, Inc. operates as a medical device company. The company is headquartered in Huntington Beach, California. The company went IPO on 2007-06-25. The firm develops and markets medical devices and technologies for the orthopedic and pain management markets. The firm develops and commercializes a platform called muscle pattern recognition (MPR), a clinical tool for the analysis of muscle function in patients presenting with back pain. MPR provides information regarding muscle recruitment patterns in patients suffering from neck and back pain that can assist healthcare professionals in the evaluation and treatment of neck and back injuries and illnesses. The Company, through BIOflex Medical Magnetics, Inc., develops and sells magnetic therapy devices. The firm sells its products through several channels, including Web-based sales; corporate partnerships; direct response television (DRTV); retail distribution; Internet catalogs, and through a network of distributors across the world.
See Also
What is Bionoid Pharma Inc's Research & Development?
Research & Development
-600k
USD
Based on the financial report for Dec 31, 2011, Bionoid Pharma Inc's Research & Development amounts to -600k USD.
What is Bionoid Pharma Inc's Research & Development growth rate?
Research & Development CAGR 5Y
-23%
Over the last year, the Research & Development growth was -25%. The average annual Research & Development growth rates for Bionoid Pharma Inc have been -66% over the past three years , -23% over the past five years .
